Merck KGaA MKGAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.97% | 8.10% | 5.80% | 7.39% | 3.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.97% | 8.10% | 5.80% | 7.39% | 3.53% |
| Cost of Revenue | 4.32% | 7.71% | 5.71% | 5.49% | 10.87% |
| Gross Profit | 7.19% | 8.36% | 5.87% | 8.68% | -1.27% |
| SG&A Expenses | 8.66% | 13.88% | 12.13% | 10.11% | 5.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 38.90% | -141.89% | 79.00% | -220.46% | -58.98% |
| Total Operating Expenses | 9.92% | 8.84% | 17.20% | 4.51% | 0.93% |
| Operating Income | -13.39% | 4.89% | -27.25% | 18.36% | 18.47% |
| Income Before Tax | -20.88% | 1.05% | -45.94% | 14.50% | 11.35% |
| Income Tax Expenses | -14.01% | 2.05% | -39.94% | 3.58% | 1.93% |
| Earnings from Continuing Operations | -22.71% | 0.75% | -47.19% | 17.61% | 14.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -36.64% | -297.69% | -82.01% | 241.79% | -258.16% |
| Net Income | -22.98% | -0.30% | -47.77% | 18.57% | 13.26% |
| EBIT | -13.39% | 4.89% | -27.25% | 18.36% | 18.47% |
| EBITDA | -3.32% | 9.20% | -4.96% | 15.49% | 12.67% |
| EPS Basic | -22.80% | -0.01% | -47.77% | 18.35% | 12.97% |
| Normalized Basic EPS | -21.03% | 0.05% | -18.42% | 15.47% | 9.98% |
| EPS Diluted | -22.80% | -0.01% | -47.77% | 18.35% | 12.97% |
| Normalized Diluted EPS | -21.03% | 0.05% | -18.42% | 15.47% | 9.98% |
| Average Basic Shares Outstanding | -0.24% | -0.29% | 0.00% | 0.18% | 0.25% |
| Average Diluted Shares Outstanding | -0.24% | -0.29% | 0.00% | 0.18% | 0.25% |
| Dividend Per Share | -- | -- | 9.21% | -- | -- |
| Payout Ratio | 0.37% | -0.67% | -- | -- | -0.05% |